Dr. Tony Johnson joined Goldfinch Bio as president and chief executive officer in 2017. He brings 25 years of academic, industry and venture experience including several years in R&D senior leadership roles. Goldfinch Bio is a biotech company focused on bringing precision medicines to patients with diseases of the kidney.

Anthony Johnson

Dr. Tony Johnson is president and chief executive officer of Goldfinch Bio and has 25 years of academic, industry and venture experience.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store